open access
Vol 26, No 5 (2019)
Editorial
Submitted: 2019-09-19
Accepted: 2019-09-19
Published online: 2019-09-19
Get Citation
ISAR-REACT 5 — What have we learned?
1, 2
Affiliations- Department of Cardiology and Internal Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- First Department of Cardiology, Medical University of Gdansk, Poland
open access
Vol 26, No 5 (2019)
Editorial
Submitted: 2019-09-19
Accepted: 2019-09-19
Published online: 2019-09-19
Abstract
Not available
Abstract
Not available
Get Citation
About this articleTitle
ISAR-REACT 5 — What have we learned?
Journal
Issue
Article type
Editorial
Pages
427-428
Published online
2019-09-19
Page views
3193
Article views/downloads
5053
DOI
Pubmed
Bibliographic record
Cardiol J 2019;26(5):427-428.
Authors
Jacek Kubica
Miłosz Jaguszewski
References (6)- Schüpke S, Neumann FJ, Menichelli M, et al. ISAR-REACT 5 Trial Investigators. Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes. N Engl J Med. 2019 [Epub ahead of print].
- Ibanez B, James S, Agewall S, et al. ESC Scientific Document Group . 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2): 119–177.
- Roffi M, Patrono C, Collet JP, et al. ESC Scientific Document Group . 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016; 37(3): 267–315.
- Valgimigli M, Bueno H, Byrne RA, et al. ESC Scientific Document Group , ESC Committee for Practice Guidelines (CPG) , ESC National Cardiac Societies . 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018; 39(3): 213–260.
- Shi L, Liu J, Fonseca V, et al. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 2010; 8: 99.
- Kubica A, Kasprzak M, Obońska K, et al. Discrepancies in assessment of adherence to antiplatelet treatment after myocardial infarction. Pharmacology. 2015; 95(1-2): 50–58.
